metastasis
The analysis of three clinical trials also suggested that NTRK fusion-positive colorectal cancers don't respond as well as other tumors to Rozlytrek.
Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium
The company failed in its first bid for breakthrough device designation but has now split out new specific indications for which it is building more persuasive utility data.
OSE Immunotherapeutics Randomizes First Patient to Phase II Trial of Vaccine in Metastatic NSCLC
The trial is evaluating its neo-epitope-based vaccine Tedopi in combination with nivolumab or chemotherapy, as compared to chemotherapy alone.
The autologous CAR T-cell therapy P-PSMA-101 demonstrated anti-tumor activity in nine metastatic castrate-resistant prostate cancer patients based on PSA levels.
Advanced Gastric Cancer Multiomic Analysis Reveals New Potential Therapeutic Targets
An integrated analysis of peritoneal metastases in advanced gastric cancer patients pointed to new molecular subgroups and treatment targets.